Senate ag leaders want changes in China's biotech approvals

Bipartisan letter calls for continued prioritization of China's delays in approving biotech products.

The ongoing dialogue between China and the U.S. has resulted in commitments from China to provide regulatory predictability and increased cooperation in areas such as biotechnology. "However, these commitments have not yet resulted in significant action from China, as there are currently outstanding products pending final approval, some of which have been awaiting approval for over five years,” according to a bipartisan letter 37 senators sent to President Barack Obama regarding ongoing d

All access premium subscription

This content requires a subscription to Feedstuffs in order to access. If you are a paid subscriber, use your email and password to Log In now.

Current Feedstuffs Subscribers: Online and mobile access are now included at no charge to you. To read this article, use your subscriber email and password to log-in to your account (or contact us for assistance in updating your account.)

Not Currently a Subscriber: Subscribe NOW to Feedstuffs and receive our print and/or digital publications, enewsletters and premium online content. Visit and click on Subscribe at the top of the page for more information.



Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.